Eculazumab (soliris)
Ended Awarded
- Contract number
- 36C25019F0479
- Awardee
-
Alexion Pharmaceuticals Inc. UEI DKCXLGANZAN3
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $58,836
Award facts
- Contract value 100% obligated
- $58,835.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Frisco, TX 75034, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 36C25019F0479?
36C25019F0479 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on November 30, 2018.
How much is contract 36C25019F0479 worth?
The government has obligated $58,836 on 36C25019F0479.
Is contract 36C25019F0479 an order under another contract?
Yes. 36C25019F0479 is a delivery order under 36F79718D0355, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25019F0479 competed?
The extent of competition for 36C25019F0479 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award